Targeting perilipin 5 ameliorates diabetic cardiomyopathy via regulating glycolysis and mitochondrial dynamics
Clinical Science · 2026
DOI: 10.1042/cs20256032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2026. Verfasst von Qing Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Yangpu District, Shang…. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Perilipin-5, Myocytes, Cardiac. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The present study investigates how perilipin 5 (Plin5), a lipid droplet-associated protein crucial for regulating intracellular lipid metabolism, modulates glycolysis, apoptosis, and mitochondrial function under high glucose conditions, with a focus on its therapeutic potential in diabetic cardiomyopathy (DCM). AC16 human cardiomyocyte cells and human cardiac fibroblasts (HCFs) were transfected with Plin5-overexpressing lentivirus. An in vivo DCM model was established in wild-type and Plin5-knockout mice using a high-fat diet (HFD) combined with streptozotocin injection. Cardiac function was evaluated, and cellular mechanisms were assessed using molecular biology techniques and single-cell RNA sequencing analysis. Plin5 overexpression significantly enhanced glycolysis (e.g. a 2.5-fold increase in extracellular acidification rate, P < 0.001) in both AC16 and HCFs. In AC16 cells, high glucose treatment up-regulated Plin5 expression, whereas in HCFs, it led to down-regulation. Apoptosis-related protein levels, including BCL-2 and cleaved Caspase-3, were modulated by Plin5 overexpression, with a notable impact under high glucose conditions. Cardiac ultrasound revealed significant differences in systolic function (ejection fraction values) across experimental groups. Ki67 staining showed enhanced cardiomyocyte proliferation in Plin5-overexpressing groups under normal glucose conditions, while TUNEL assays indicated reduced apoptosis, though this effect was attenuated under high glucose conditions. Bioinformatics analysis revealed a significant up-regulation of fatty acid metabolism pathways in the diabetic heart, with Plin5 expression specifically increased in cardiomyocytes. In summary, the present study demonstrates that Plin5 plays a critical role in regulating glycolysis, apoptosis, and cardiomyocyte proliferation, particularly under varying glucose conditions, identifying it as a potential therapeutic target for DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Yangpu District, Shanghai 200092, China.
ORCID-Profile: Kai Guo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Q., & Guo, K. (2026). Targeting perilipin 5 ameliorates diabetic cardiomyopathy via regulating glycolysis and mitochondrial dynamics. Clinical Science. https://doi.org/10.1042/cs20256032
Vancouver
Zhou Q, Guo K. Targeting perilipin 5 ameliorates diabetic cardiomyopathy via regulating glycolysis and mitochondrial dynamics. Clinical Science. 2026. doi:10.1042/cs20256032
BibTeX
@article{Zhou2026,
author = {Zhou, Qing and Guo, Kai},
title = {Targeting perilipin 5 ameliorates diabetic cardiomyopathy via regulating glycolysis and mitochondrial dynamics},
journal = {Clinical Science},
year = {2026},
doi = {10.1042/cs20256032}
}
EUVIMED